The effect of platelet-rich plasma formulations and blood products on human synoviocytes: Implications for intra-articular injury and therapy

American Journal of Sports Medicine

Volumn 42, Issue 5, 2014, Pages 1204-1210

  Braun, Hillary J ^a,b   Kim, Hyeon Joo ^a   Chu, Constance R ^a   Dragoo, Jason L ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

inflammation; osteoarthritis; platelet rich plasma; synoviocytes

Indexed keywords

BUFFER; CYTOKINE; PHOSPHATE; SODIUM CHLORIDE;

ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CYTOLOGY; ERYTHROCYTE; HUMAN; INFLAMMATION; LEUKOCYTE; OSTEOARTHRITIS; PHYSIOLOGY; SYNOVIOCYTES; SYNOVIUM; THROMBOCYTE RICH PLASMA;

INFLAMMATION; OSTEOARTHRITIS; PLATELET-RICH PLASMA; SYNOVIOCYTES;

BUFFERS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; ERYTHROCYTES; HUMANS; LEUKOCYTES; PHOSPHATES; PLATELET-RICH PLASMA; SODIUM CHLORIDE; SYNOVIAL MEMBRANE;

EID: 84900393301     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546514525593     Document Type: Article

References (42)

1. Atsumi T, Ishihara K, Kamimura D, et al. A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. J Exp Med. 2002 ; 196 (7). 979-990
2. Barrett SL, Erredge SE. Growth factors for chronic plantar fasciitis. Podiatry Today. 2004 ; 17: 37-42
3. Berghoff WJ, Pietrzak WS, Rhodes RD. Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics. 2006 ; 29 (7). 590-598
4. Browning SR, Weiser AM, Woolf N, et al. Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. J Bone Joint Surg Am. 2012 ; 94 (23). e1721 - e1727
5. Chandrasekhar S, Harvey AK, Hrubey PS. Intra-articular administration of interleukin-1 causes prolonged suppression of cartilage proteoglycan synthesis in rats. Matrix. 1992 ; 12 (1). 1-10
6. DeHaven KE. Diagnosis of acute knee injuries with hemarthrosis. Am J Sports Med. 1980 ; 8 (1). 9-14
7. Dragoo JL, Braun HJ, Durham JL, et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012 ; 40 (6). 1274-1281
8. Elsaid KA, Fleming BC, Oksendahl HL, et al. Decreased lubricin concentrations and markers of joint inflammation in the synovial fluid of patients with anterior cruciate ligament injury. Arthritis Rheum. 2008 ; 58 (6). 1707-1715
9. Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011 ; 19 (4). 528-535
10. Filardo G, Kon E, Di Martino A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012 ; 13: 229
11. Gardner MJ, Demetrakopoulos D, Klepchick PR, Mooar PA. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty: an analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop. 2007 ; 31 (3). 309-313
12. Gobbi A, Karnatzikos G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health. 2012 ; 4 (2). 162-172
13. Halpern B, Chaudhury S, Rodeo SA, et al. Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis. Clin J Sport Med. 2013 ; 23 (3). 238-239
14. Helder AE, Feltkamp-Vroom TM, Nienhuis RL. Electron and light microscopical observations and serological findings in rheumatoid arthritis. Ann Rheum Dis. 1973 ; 32 (6). 515-523
15. Henderson B, Pettipher ER. The synovial lining cell: biology and pathobiology. Semin Arthritis Rheum. 1985 ; 15 (1). 1-32
16. Hooiveld M, Roosendaal G, Vianen M, van den Berg M, Bijlsma J, Lafeber F. Blood-induced joint damage: long-term effects in vitro and in vivo. J Rheumatol. 2003 ; 30 (2). 339-344
17. Horai R, Saijo S, Tanioka H, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med. 2000 ; 191 (2). 313-320
18. Irie K, Uchiyama E, Iwaso H. Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. Knee. 2003 ; 10 (1). 93-96
19. Jang SJ, Kim JD, Cha SS. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol. 2013 ; 23 (5). 573-580
20. Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991 ; 10 (13). 4025-4031
21. Kon E, Buda R, Filardo G, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010 ; 18 (4). 472-479
22. Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011 ; 27 (11). 1490-1501
23. Marks PH, Donaldson ML. Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament-deficient knee. Arthroscopy. 2005 ; 21 (11). 1342-1347
24. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006 ; 34 (11). 1774-1778
25. Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol. 2005 ; 115 (2). 118-128
26. Morris CJ, Blake DR, Wainwright AC, Steven MM. Relationship between iron deposits and tissue damage in the synovium: an ultrastructural study. Ann Rheum Dis. 1986 ; 45 (1). 21-26
27. Noss EH, Brenner MB. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev. 2008 ; 223: 252-270
28. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013 ; 41 (2). 356-364
29. Roosendaal G, Vianen ME, Marx JJ, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: a human in vitro study. Arthritis Rheum. 1999 ; 42 (5). 1025-1032
30. Roosendaal G, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Cartilage damage as a result of hemarthrosis in a human in vitro model. J Rheumatol. 1997 ; 24 (7). 1350-1354
31. Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil. 2010 ; 89 (12). 961-969
32. Sanchez M, Anitua E, Azofra J, Aguirre JJ, Andia I. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol. 2008 ; 26 (5). 910-913
33. Scioli M. Treatment of recalcitrant enthesopathy of the hip with platelet rich plasma - a report of three cases. Clin Orthop Soc News. 2006 ;: 6-7
34. Smyth NA, Murawski CD, Fortier LA, Cole BJ, Kennedy JG. Platelet-rich plasma in the pathologic processes of cartilage: review of basic science evidence. Arthroscopy. 2013 ; 29 (8). 1399-1409
35. Spakova T, Rosocha J, Lacko M, Harvanova D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012 ; 91: 411-417
36. Stein H, Duthie RB. The pathogenesis of chronic haemophilic arthropathy. J Bone Joint Surg Br. 1981 ; 63 (4). 601-609
37. Torrero JI, Aroles F, Ferrer D. Treatment of knee chondropathy with platelet rich plasma: preliminary results at 6 months of follow-up with only one injection. J Biol Regul Homeost Agents. 2012 ; 26 (2). 71S - 78S
38. Valentino LA, Hakobyan N, Kazarian T, Jabbar KJ, Jabbar AA. Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency. Haemophilia. 2004 ; 10 (3). 280-287
39. van Buul GM, Koevoet WL, Kops N, et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med. 2011 ; 39 (11). 2362-2370
40. van den Berg WB, Joosten LA, van de Loo FA. TNF alpha and IL-1 beta are separate targets in chronic arthritis. Clin Exp Rheumatol. 1999 ; 17 (6). S105 - S114
41. van Meegeren ME, Roosendaal G, Coeleveld K, Nieuwenhuizen L, Mastbergen SC, Lafeber FP. A single intra-articular injection with IL-4 plus IL-10 ameliorates blood-induced cartilage degeneration in haemophilic mice. Br J Haematol. 2013 ; 160 (4). 515-520
42. van Meegeren ME, Roosendaal G, Jansen NW, et al. IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage. Osteoarthritis Cartilage. 2012 ; 20 (7). 764-772